SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-027413
Filing Date
2022-05-17
Accepted
2022-05-17 07:05:20
Documents
3
Period of Report
2022-05-17

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea160091-6k_kamadaltd.htm 6-K 14118
2 KAMADA REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS; REITERATES REVENUE AND PROF ea160091ex99-1_kamadaltd.htm EX-99.1 158564
3 KAMADA LTD.'S CONSOLIDATED FINANCIAL STATEMENTS AS OF MARCH 31, 2022 (UNAUDITED) ea160091ex99-2_kamadaltd.htm EX-99.2 266030
  Complete submission text file 0001213900-22-027413.txt   439688
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Filer) CIK: 0001567529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35948 | Film No.: 22932219
SIC: 2834 Pharmaceutical Preparations